Why the study?
Does inhibition of initial platelet adherence with PGI2 or dipyridamole influence the development of nonthrombogenicity in injured rabbit aortas?
Population
Rabbit model with injured aortas (removal of endothelium from normal aortas or injury to neointima)
Design
Preclinical
Follow-up
8 hours
Authors
Loading...
Supports vessel passivation after platelet inhibition in rabbit injury models; leaves open translation to human antithrombotic strategies.
Does inhibition of initial platelet adherence with PGI2 or dipyridamole influence the development of nonthrombogenicity in injured rabbit aortas?
Injured vessel walls can develop a nonthrombogenic surface over approximately 8 hours even when initial platelet adherence is pharmacologically prevented.
Groves et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: